[CH2:1]([O:3][C:4]([CH:6]1[CH2:11][CH2:10][CH:9]([N:12]2[CH2:15][CH:14]([NH:16][C:17](=[O:40])[CH2:18][NH:19][C:20]3[C:28]4[C:23](=[CH:24][CH:25]=[C:26]([C:29]([F:32])([F:31])[F:30])[CH:27]=4)[N:22]([C:33](=[O:39])[NH:34]C(C)(C)C)[N:21]=3)[CH2:13]2)[CH2:8][CH2:7]1)=[O:5])[CH3:2].C(O)(C(F)(F)F)=O>>[CH2:1]([O:3][C:4]([CH:6]1[CH2:7][CH2:8][CH:9]([N:12]2[CH2:15][CH:14]([NH:16][C:17](=[O:40])[CH2:18][NH:19][C:20]3[C:28]4[C:23](=[CH:24][CH:25]=[C:26]([C:29]([F:31])([F:32])[F:30])[CH:27]=4)[N:22]([C:33](=[O:39])[NH2:34])[N:21]=3)[CH2:13]2)[CH2:10][CH2:11]1)=[O:5])[CH3:2]The title compound was prepared as a white solid from de-protection of 4-{3-[2-(1-tert-butylcarbamoyl-5-trifluoromethyl-1H-indazol-3-ylamino)-acetylamino]-azetidin-1-yl}-cyclohexanecarboxylic acid ethyl ester (as prepared in Example 88) with TFA using the procedure described in Example 81.